RZ-629

N/A

Report date: 2025/02/20 20:00:06
NME

Base Information

Drug NameRZ-629
Drug Alias NameRZ-629RZ629
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 1 agonists
TargetsFree fatty acid receptor 1
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesRezubio Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRezubio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A